Colgate-Palmolive Company(CL)Earnings, Financials & Key RatiosColgate-Palmolive Company (CL) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company generates significant free cash flow with a 24.4% margin in 2025Q4, the elevated debt-to-equity ratio of 16.41 and high P/E multiple of 35.01 suggest limited near-term valuation upside.
Colgate-Palmolive Company (CL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Colgate-Palmolive Company (CL) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 1, 2026 | $0.97vs $0.94+2.9% | $5.3Bvs $5.2B+2.1% |
| Q1 2026 | Jan 30, 2026 | $0.95vs $0.91+4.2% | $5.2Bvs $5.1B+2.1% |
| Q4 2025 | Oct 31, 2025 | $0.91vs $0.89+2.4% | $5.1Bvs $5.1B+0.1% |
| Q3 2025 | Aug 1, 2025 | $0.92vs $0.90+2.6% | $5.1Bvs $5.0B+1.5% |
Recent stock market news and headlines for Colgate-Palmolive Company (CL)
Procter & Gamble (NYSE:PG | PG Price Prediction) and Colgate-Palmolive (NYSE:CL) both posted top and bottom line beats in their most recent quarters.
Colgate-Palmolive has risen more than 16% this year while also increasing its dividend.
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CL stock's strength reflects solid momentum, but inflation, North America softness and a premium valuation could keep new buyers waiting.
Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of Ollie's Bargain Outlet (OLLI) and Colgate-Palmolive (CL). But which of these two stocks is more attractive to value investors?
Key metrics vs top competitors for Colgate-Palmolive Company (CL)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $93.39 | $74.73B | 35.51 | 1.4% | 10.46% | 469.09% | 2.41% | |
| $149.31 | $348.9B | 22.94 | 0.29% | 14.66% | 23.78% | — | |
| $61.58 | $133.35B | 20.82 | -16.88% | 10.62% | 56.91% | — | |
| $113.01 | $37.51B | 18.62 | -14.17% | 12.81% | 131.68% | — | |
| $97.45 | $23.08B | 32.27 | 1.57% | 11.81% | 17.45% | — | |
| $21.34 | $1.46B | 6.43 | 2.28% | 6.55% | 116.9% | — |
Colgate-Palmolive Company (CL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Colgate-Palmolive Company (CL) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 13, 2026·SEC
Apr 9, 2026·SEC
Mar 17, 2026·SEC
Get notified when CL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Colgate-Palmolive Company (CL) stock FAQ — growth, dividends, profitability & financials explained
Colgate-Palmolive Company (CL) reported $20.80B in revenue for fiscal year 2025. This represents a 138% increase from $8.75B in 1996.
Colgate-Palmolive Company (CL) grew revenue by 1.4% over the past year. Growth has been modest.
Yes, Colgate-Palmolive Company (CL) is profitable, generating $2.09B in net income for fiscal year 2025 (10.5% net margin).
Yes, Colgate-Palmolive Company (CL) pays a dividend with a yield of 2.41%. This makes it attractive for income-focused investors.
Colgate-Palmolive Company (CL) has a return on equity (ROE) of 469.1%. This is excellent, indicating efficient use of shareholder capital.
Colgate-Palmolive Company (CL) generated $3.77B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
